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Rapid, selective and stable HaloTag-LbADH
immobilization directly from crude cell extract for
the continuous biocatalytic production of chiral
alcohols and epoxides†
J. Döbber,ab M. Pohl,a S. V. Ley b and B. Musio *b
A strategy for biocatalyst immobilization in flow directly from the
crude cell extract is described. The efficiency and the stability of
the immobilized enzyme were demonstrated during the
asymmetric reduction of a range of ketones. The cascade two-
step chemo-enzymatic preparation of chiral epoxides was possible
through the initial ketone bioreduction to an intermediate halo-
hydrin followed by its intramolecular cyclization.
The use of biocatalytic methods in continuous processes for
more sustainable chemistry applications has been growing
over the last few years.1 The benefits arising from the
continuous biotransformations are clear in terms of re-
usability of non-toxic catalysts, high selectivity, mild and ac-
curately controlled reaction conditions, reduction of protec-
tion–deprotection steps and easy scale-up through improved
downstream processing.2 However, the implementation of
continuous biocatalytic processes demands a high operational
stability of enzymes, which is still an existing concern espe-
cially in the presence of conventional media such as organic
solvents.3 Furthermore, the availability and stability of en-
zymes can be limiting.
Enzyme immobilization technologies, which lead to the
formation of an insoluble biocatalyst, in some cases can aid
efficient recycling and an enhanced operational stability. Ide-
ally, enzyme immobilization should proceed rapidly to main-
tain enzyme activity and result in a biocatalyst formulation
that does not leach. Additionally, the ideal arrangement
would be cheap to produce and would avoid excessive waste.4
Particularly interesting for flow applications is the pros-
pect of preparing plug-flow reactors containing the desired
immobilized biocatalyst using simple procedures.
Recently, we reported on an innovative immobilization
strategy based on the commercially available HaloTag™ tech-
nology (Promega).5 The HaloTag™ is a modified
dehalogenase enzyme from Rhodococcus species6 that can be
genetically fused to an enzyme to effect rapid binding from a
crude cell extract. This fusion tag recognizes terminal chloro-
alkane substituents exposed on the surface of the HaloLink™
resin and affords a stable covalent ester bond via a self-
terminating mechanism thereby immobilizing the target en-
zyme (Fig. 1). We applied this concept successfully for the
one-step purification and immobilization of the benzalde-
hyde lyase from Pseudomonas fluorescence (PfBAL) and could
prove its usefulness for the efficient recycling of PfBAL in re-
petitive batch reactions.5
Here we extend the HaloTag™ method to a continuous
biocatalytic production process involving the alcohol dehy-
drogenase from Lactobacillus brevis (LbADH).7 LbADH is a
complex biocatalyst system consisting of four subunits
forming a tetramer to achieve the active conformation. The
non-covalently bound cofactor NADPH is also essential for ca-
talysis and must be recycled efficiently to make the corre-
sponding biotransformations economically viable. For the
LbADH, different strategies for cofactor regeneration have
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Fig. 1 Schematic overview of the HaloTag-LbADH enzyme
immobilization on the HaloLink™ resin. The HaloLink™ resin consists
of Sepharose beads and is visualized as green spheres. The HaloTag™
was genetically fused to the LbADH and recognizes the terminal
chloroalkane ligands to establish a covalent ester bond thereby
immobilizing the biocatalyst.
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been developed, including enzyme engineering or substrate-
coupled approaches.8
In this study we demonstrate an easy and rapid prepara-
tion of a packed-bed flow reactor by immobilizing the fusion
enzyme directly from the crude cell extracts from the respec-
tive recombinant E. coli production host immediately prior to
conducting the biotransformation. Furthermore, we evaluate
the performance of the immobilized biocatalyst for the con-
tinuous asymmetric reduction of a range of ketones to the
corresponding chiral alcohols. Finally, we demonstrate the
high operational stability of the new immobilized HaloTag-
LbADH and its use in organic solvents for possible multi-step
transformations.
In the first stage, the HaloTag™ was genetically fused to
the N-terminus of the LbADH resulting in the fusion enzyme
HaloTag-LbADH. After successful production of this fusion
enzyme in E. coli BL21 (DE3) cells, we verified its activity as a
biocatalyst in comparison to the non-immobilized, untagged
LbADH. Thus, HaloTag-LbADH was immobilized in batch to
the HaloLink™ resin directly from the crude cell extract by
incubation for 1 h at 25 °C (see ESI† for more details). The
activity was analyzed following the reduction of benzaldehyde
to benzyl alcohol in an aqueous buffer (Fig. 2, conditions A).
The immobilized HaloTag-LbADH exhibited a residual activity
of 35% by comparison to the reference. A similar reduced ac-
tivity of an immobilized biocatalyst with respect to the free
reference system is a common outcome and can be explained
by different reasons. First, the physical confinement of the
enzyme on the support can lead to a reduced flexibility, thus
affecting the activity. Additionally, the immobilization and
the high local concentration of an enzyme on a support may
cause mass-transfer limitations in comparison to soluble sys-
tems. Importantly, in the case of complex tetrameric enzymes
carrying four individual HaloTags, such as HaloTag-LbADH,
steric hindrance of the active site, may be an issue. In this
case the size per subunit of the enzyme was more than dou-
bled by the HaloTag-fusion from 252 amino acids (26.76
KDa) for the native enzyme to 581 amino acids (63.58 KDa)
for the HaloTag-LbADH fusion enzyme. By contrast, the previ-
ously immobilized tetrameric HaloTag-PfBAL fusion enzyme5
revealed a residual activity of 65% indicating that the influ-
ence of the tag cannot be predicted and seems to depend on
the relative sizes and overall conformation of the particular
fusion partners. Then, we investigated the influence of the
sacrificial co-substrate 2-propanol on the activity of the free
LbADH and the immobilized HaloTag-LbADH (Fig. 2, condi-
tions B). 2-Propanol is generally used for the substrate-
coupled cofactor regeneration, being oxidized to acetone by
LbADH thereby reducing NADP+ to NADPH.8a Both enzyme
variants were less active in the presence of 2-propanol (10
vol%). However, the activity of the free, untagged LbADH was
reduced by 75%, while the immobilized HaloTag-LbADH vari-
ant lost only half of its activity. This observation indicates
that the immobilized HaloTag-LbADH was relatively more sta-
ble against the detrimental effects of 2-propanol and that im-
mobilization of the enzyme led to the formation of a more ro-
bust catalyst. We also compared the activity of the free,
untagged LbADH with the activity of the immobilized Halo-
Tag-LbADH in a buffer/THF/2-propanol system (Fig. 2, condi-
tions C).
The activity of the free LbADH as well as of the
immobilized HaloTag-LbADH decreased further in the pres-
ence of THF. However, no difference in activity between both
the free and the immobilized enzyme was observed although
the difference in the buffered system was shown to be about
65% (Fig. 2, conditions A).
As a next step, the preparation of a packed-bed reactor
was investigated. Thus, an Omnifit® column (30 MM ×
50 MM) was filled with HaloLink™ resin (360 mg wet
weight) and connected to an Asia Syringe Pump (Syrris,
Royston, United Kingdom) to drive the flow streams. The
column was then loaded with a solution of crude cell ex-
tract containing the HaloTag-LbADH fusion enzyme. The
efflux was re-circulated and its UV absorption (282 nm)
was continuously monitored in-line by a UV/Vis detector
(Flow-UVTM, Uniqsis Ltd) provided with a high pressure
flow cell and a 220–1050 nm Xenon pulsing lamp
(Fig. 3a). The solid packed bed appeared to be saturated
with HaloTag-LbADH after 216 min of continuous re-
circulation of the crude cell extract solution as was indi-
cated by a constant UV absorbance (Fig. 3b, solid line).
Then, the reactor was washed to elute all the non-
specifically bound proteins until the absorbance of the ef-
flux reached the baseline (Fig. 3b, dashed line). Finally,
the resin was removed from the column to evaluate the
immobilization and to determine the purity of the bound
enzyme. Thus, the ester bond connecting the HaloTag™
with the HaloLink™ resin was saponified by treatment
with sodium dodecyl sulfate (SDS) and NaOH and a
Fig. 2 Activity of immobilized HaloTag-LbADH in different solvent
systems compared to the free, untagged LbADH. Initial rate activities
were analyzed by HPLC following the reduction of benzaldehyde (20
mM) to benzyl alcohol in a total volume of 1 ml at 25 °C. Conditions A:
NADPH (20 mM), KPi 50 mM (pH 7.0), MgCl2·H2O (1 mM); conditions B:
NADPH (0.5 mM), 2-propanol (10 vol%), KPi 50 mM (pH 7.0), MgCl2
·H2O (1 mM); conditions C: NADPH (0.5 mM), 2-propanol (10 vol%),
THF (10 vol%), KPi 50 mM (pH 7.0), MgCl2·H2O (1 mM). Error bars rep-
resent the variance of three activity measurements from the same
sample.
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sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) analysis was performed.
The HaloTag-LbADH was efficiently immobilized with a
very high purity since almost no contamination was observed
on the HaloLink™ resin and the protein band corresponding
to one monomer of the HaloTag-LbADH (63 kDa per mono-
mer) predominated markedly (Fig. 3c).
The total amount of protein (4 mg) present on 360 mg wet
resin was determined by using the bicinchoninic acid (BCA)
assay.
Once the feasibility of preparing a biocatalytic packed-
bed bioreactor directly from the crude cell extracts was dem-
onstrated, its efficiency in catalyzing the asymmetric reduc-
tion of a range of ketones was explored particularly in terms
of reaction conditions and stability of the bioreactor. First,
we aimed to find the appropriate 2-propanol concentration
necessary for optimal cofactor regeneration, thereby en-
abling highest conversion and maximal enzyme activity and
stability. Thus, the reduction of acetophenone 1a to (R)-
phenylethanol 2a was first studied in batch mode. As the
2-propanol concentration influences the thermodynamic
equilibrium of the reaction, usually an excess is necessary to
reach a high conversion. However, a high 2-propanol con-
centration may affect the enzyme activity as well as stability.
We observed a decreased activity of the immobilized Halo-
Tag-LbADH with increasing concentrations of 2-propanol,
though the biocatalyst remained remarkably active even in
presence of 2-isopropanol 90 vol% (Fig. S1 in ESI†). Aiming
at understanding the effect of 2-propanol on the stability of
the immobilized HaloTag-LbADH, repetitive reactions were
performed by examining the same batch of immobilized
biocatalyst in the presence of different concentrations of
2-propanol ranging between 10 vol% and 90 vol%. In gen-
eral, the enzyme was highly stable under all the test condi-
tions. No loss of activity between the repetitive reactions
was observed for reactions with 2-propanol 10–25 vol%, and
only a slight decrease after the fourth cycle was observed for
reactions performed with higher concentrations up to 90
vol% (Fig. S2–S6 in ESI†). With this evidence in hand, we
moved on to study the reduction of acetophenone 1a in flow
using the prepared HaloTag-LbADH packed-bed reactor. The
corresponding (R)-phenylethanol 2a could be obtained with
95% conversion when a solution of acetophenone (50 mM)
and NADPH (0.5 mM) in a mixture of Kpi 50 mM (90 vol%)
and 2-propanol (10 vol%) was passed continuously through
the packed-bed reactor (flow rate 30 μl min−1). Higher sub-
strate concentrations (50–100 mM) and faster flow rates (up
to 100 μl min−1) were also tested, but the reaction occurred
in all cases with lower conversion. More importantly, this re-
action was continued over several days and stopped after
138 h, with no loss in activity (see ESI† for experimental
details).
To enable the reduction of other ketones, which were less
soluble in the buffer/2-propanol solvent system, the addition
of conventional co-solvents was considered. Methyl tert-butyl
ether (MTBE), dimethyl sulfoxide (DMSO), acetonitrile (ACN),
dimethylformamide (DMF) and tetrahydrofuran (THF) were
evaluated for the reduction of 4′-bromoacetophenone 1b as a
test case. It was found that the formation of a biphasic or
emulsion solvent system was not favorable for the reaction.
Among the solvents screened, only THF (30 vol%) gave en-
couraging results giving access to the corresponding (R)-4′-
bromophenylethanol 2b with high yield (94%) and excellent
ee (>99%). When a lower THF concentration was added to
the reaction mixture, the substrate and the product were par-
tially trapped within the packed bed, as demonstrated by UV
absorption of the efflux and by the low mass recovery after
the reaction work-up. Next, starting from a range of prochiral
ketones, we demonstrated the generality of this synthetic
strategy for the preparation of a number of chiral alcohols
(Fig. 4). The immobilized HaloTag-LbADH system exhibited a
good catalytic activity towards a range of substrates, includ-
ing substituted aromatic ketones (1a–1l), an aliphatic ketone
(1m, the ee of 2m was determined by HPLC analysis of the
corresponding benzoate derivative), a β-ketoester (1n) and an
alkynyl ketone (1o).
The obtained results are in excellent agreement with the
reported data describing the dependence of the relative activ-
ity of LbADH on the steric and electronic effects due to the
substrate nature and on the thermodynamic stability of the
products.9 The activity of the bioreactor remained constant
under these reaction conditions, as demonstrated by the
continuous production of (R)-(−)-2n starting from
benzylacetoacetate 1n, with a total amount of pure com-
pound equated to 420 mg (2.16 mmol) produced over 24 h.
After a washing step with buffer, the biocatalytic solid bed
Fig. 3 a) Set-up for the immobilization of the HaloTag-LbADH directly
from the crude cell extracts with in-line UV analysis at 282 nm (Field
Progammable Gate Array, FPGA; Printed Circuit Board, PCB). b) In-line
monitoring during the immobilization step (solid line) during the un-
bound proteins elution step (dashed line). c) SDS-PAGE analysis of
HaloTag-LbADH before (CE) and after immobilization (I). M:
PageRuler™ Plus Prestained Ladder (ThermoFisher Scientific,
Germany).
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demonstrated to be still active and efficient for another
reaction.
Finally, we explored the feasibility of an enantioselective
two-step chemo-enzymatic synthesis of the chiral epoxide (S)-
5, using the bio-reduction to form the intermediate halo-
hydrin 2h, which was immediately cyclized in a glass micro-
reactor under basic conditions (pH 13, Fig. 5). The corre-
sponding (S)-2-phenyloxirane 5 could be obtained in a short
time (35 minutes) with high conversion (98%) and excellent
ee (98%). This experiment demonstrated the advantages of
the flow-plug technology in multi-step processes, allowing a
quick change of the reaction conditions and an efficient com-
partmentalization of the synthetic steps.
In conclusion, we have designed a new methodology for
the fast preparation of cartridges containing a stable, cova-
lently immobilized enzyme, starting directly from the crude
cell extracts without any need of previous enzyme chromato-
graphic purification step. The resulting packed bed bioreac-
tor was then used for the continuous enantioselective produc-
tion of chiral alcohols with the re-use of the catalyst. The
application of this bioreactor to multi-step processes was
demonstrated during the two-step chemo-enzymatic transfor-
mation of 2-bromoacetophenone into (S)-2-phenyloxirane,
with benefits resulting from improved downstream process-
ing. The relative ease of construction of the bioreactor and
its robustness, even in the presence of THF as co-solvent,
opens up wider opportunities for synthesis.
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